Arbitration Confirms NovelStem Joint Venture's Rights to Exploit 'Tom Clancy's Net Force' Franchise Globally via Film, TV, Online, Streaming, Gaming and Merchandising
Boca Raton, Florida--(Newsfile Corp. - July 13, 2023) - NovelStem International Corp. (OTC Pink: NSTM) announced today that an Arbitrator has confirmed Netco Partners' rights to broadly license the "Net Force" concept with the Tom Clancy name as a possessory credit (Tom Clancy's Net Force) in TV, streaming, online, films and video games, including all ancillary rights. The Net Force concept is considered to have pioneered storytelling in the thrilling, fast-paced worlds of digital crimes,...
2023-07-13 4:03 PM EDT
NovelStem, Focused on a Patented Genetic Platform Technology for Anti-Cancer Therapies, Reports 2022 Results on Form 10-K
Boca Raton, Florida--(Newsfile Corp. - March 31, 2023) - NovelStem International Corp. (OTC Pink: NSTM), a development-stage company focused on the stem cell-based technology platform developed by Israel-based NewStem Ltd., today filed its Form 10-K for the year ended December 31, 2022. NovelStem owns a 30.58% equity interest in NewStem Ltd.NovelStem's 10-K filing is available here: https://www.sec.gov/ix?doc=/Archives/edgar/data/0000912544/000149315223010137/form10-k.htmPlease contact...
2023-03-31 2:54 PM EDT
NovelStem's Affiliate NewStem Announced New Collaboration to Validate Its Software Diagnostic Device for Two Oncology Indications and Two Therapies
Israel and Boca Raton, Florida--(Newsfile Corp. - December 14, 2022) - NovelStem International Corp. (OTC Pink: NSTM), a biotechnology company focused on the stem cell-based technology platform developed by 31%-owned, Israel-based NewStem Ltd., today announced NewStem's collaboration with the MSK Innovation Hub to further optimize and validate NewStem's bioinformatics-based software as a medical device diagnostic platform. The NewStem Software Diagnostic Device ("NSDD") provides information...
2022-12-14 8:01 AM EST
NovelStem Now an SEC-Reporting Company, Secures Commitment for up to $600K in Bridge Funding, Provides Financial Update
Boca Raton, Florida--(Newsfile Corp. - October 13, 2022) - NovelStem International Corp. (OTC Pink: NSTM), a development-stage company focused on the stem cell-based technology platform developed by 30%-owned, Israel-based NewStem Ltd., today announced that it has become an SEC-reporting company following the automatic effectiveness of its Form 10 registration statement filed August 2, 2022. NovelStem filed a Form 10 Amendment yesterday, which included its results of operations for the six...
2022-10-13 12:01 PM EDT
NovelStem Announces FDA Pre-Submission and EMA In Vitro Diagnostic Device Filing for Revolutionary Life-Saving, Treatment-Changing Diagnostic Device by 30%-Owned NewStem, Ltd
Israel and Boca Raton, Florida--(Newsfile Corp. - April 11, 2022) - NovelStem International Corp. (OTC Pink: NSTM), a biotechnology company focused on the stem cell-based technology platform developed by 30%-owned, Israel-based NewStem Ltd., today announced NewStem's filing of a pre-submission to the FDA for a De Novo Request and an in vitro diagnostic device (IVDD) for Europe, the Middle East and Africa (EMA) for their NewStem Software Diagnostic Device. The announcement followed the...
2022-04-11 11:58 AM EDT
NovelStem Reviews Efforts to Maximize Value from Legacy Entertainment Asset
Boca Raton, Florida--(Newsfile Corp. - February 15, 2022) - NovelStem International Corp. (OTC Pink: NSTM), a biotechnology company focused on the stem cell-based technology platform developed by 30%-owned, Israel-based NewStem, Ltd., today reviewed progress regarding ongoing efforts to maximize shareholder value from its legacy 50% ownership in Netco Partners, which owns the Net Force publishing and entertainment franchise.NovelStem Chairman, Jan Loeb, commented, "We have initiated an...
2022-02-15 9:00 AM EST
NovelStem Announces NewStem, Ltd. Was Selected by Illumina for its Global Illumina Accelerator
Florida and Jerusalem, Israel--(Newsfile Corp. - September 20, 2021) - NovelStem International Corp. (OTC Pink: NSTM), a biotechnology company focused on the stem cell-based technology platform developed by 30%-owned Israel-based, NewStem, Ltd., announced that NewStem, along with six other genomic companies, was selected by Illumina for its global Illumina Accelerator. Illumina Accelerator is a company creation engine that focuses on partnering with and building companies with unique genomic...
2021-09-20 1:46 PM EDT